NCT01284660View on ClinicalTrials.gov

Docosahexaenoic Acid (DHA) Effects on Cognitive Function, Craving and Psychosocial Factors in Heavy Cigarette Smokers

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

September 30, 2013

Conditions
HEAVY TOBACCO SMOKERS
Interventions
DIETARY_SUPPLEMENT

DHA

DHA ingested orally by heavy smokers

DIETARY_SUPPLEMENT

Oral ingestion of 5 placebo tablets

Oral ingestion of 5 tablets containing the following: gelatin,glycerine,water and soy oil made by the Solgar Pharmaceutical Co., Israel

Trial Locations (1)

52900

Bar Ilan University, Ramat Gan

All Listed Sponsors
lead

Hillel Yaffe Medical Center

OTHER_GOV

NCT01284660 - Docosahexaenoic Acid (DHA) Effects on Cognitive Function, Craving and Psychosocial Factors in Heavy Cigarette Smokers | Biotech Hunter | Biotech Hunter